NHS England and Wales to Offer Ponvory at Low or No Cost for RRMS

NHS England and Wales to Offer Ponvory at Low or No Cost for RRMS

315083

NHS England and Wales to Offer Ponvory at Low or No Cost for RRMS

The National Institute for Health and Care Excellence (NICE) has recommended that Ponvory (ponesimod) be offered through the National Health Service (NHS) of England and Wales to people with relapsing remitting multiple sclerosis (RRMS). The decision, which reverses an earlier rejection by the agency, means that the oral treatment will soon be available at low or no cost through each country’s public health system. With this recommendation, the NHS England is required to support prescribing Ponvory…

You must be logged in to read/download the full post.